Clinical trial of Tagar Tablet in Hypertension.
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2024/03/064721
- Lead Sponsor
- Dr Vidya Rajendra Jatti
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients having Stage I hypertension, isolated systolic and isolated diastolic hypertension.
2. Patients who is known case of Hypertension but not suffering from more than 10 years. Also known case of hypertension with or without antihypertensive.
3. Shirashool, Bhrama, Klama, Hridspandana, Anidra, Swedadhikya ,Shwaskashtata patient having these symptoms of Hypertension will be included in the clinical study .
4. Patients in between 20 to 60 years of age.
5. Patients having serum creatinine level less than 1.5 mg/dl.
6. Patients with raised blood pressure with Beta blocker.
1. Patients having Stage II, stage III and above known case of hypertension will be excluded.
2. Pregnant women and lactating mothers.
3. Patient suffering from any other serious systemic illness like cerebrovascular diseases, Acute Haemorrhagic conditions, Acute septic shock etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Blood pressure monitoring <br/ ><br>2.Serum creatinine <br/ ><br>3.Lipid Profile <br/ ><br>4. ECGTimepoint: At base line, 15 days and 30 days
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil